{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-110305","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2022-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.525254+00:00","generated_at":"2026-06-23T02:23:09.365896+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"P3 Q2 revenue $269.5M (+86% YoY); CFO resigns, interim named; FY22 revenue guidance raised to $1.025-1.075B","bullets":["CFO Eric Atkins resigns effective Nov 1, 2022; Erin Darakjian appointed interim CFO (VP & CAO since Aug 2022).","Q2 revenue $269.5M (+86% YoY); net loss $903.1M includes $851.5M goodwill impairment.","Adjusted EBITDA loss PMPM improved to $94 from $119 in Q2 2021.","Raising full-year 2022 revenue guidance to $1.025-1.075B (from $637M in 2021).","At-risk Medicare Advantage members exceed 100k as of June 30; expanded Humana partnership in Nevada."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-110305","json":"https://secwatch.observer/filing/0001104659-22-110305.json","markdown":"https://secwatch.observer/filing/0001104659-22-110305.md","text":"https://secwatch.observer/filing/0001104659-22-110305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/0001104659-22-110305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/tm2228527d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:23:09.365896+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81469dbddb","claim":"Erin Darakjian was appointed as Interim Chief Financial Officer at P3 Health Partners Inc..","evidence_excerpt":"On October 18, 2022, the Board of Directors (the “Board”) of the Company appointed Erin Darakjian to serve as Interim Chief Financial Officer of the Company, effective as of the Effective Date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/0001104659-22-110305-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"fbeeafb4f3","claim":"Eric Atkins resigned as Chief Financial Officer at P3 Health Partners Inc..","evidence_excerpt":"On October 14, 2022, Eric Atkins notified the Company of his resignation as Chief Financial Officer of the Company, effective as of November 1, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465922110305/0001104659-22-110305-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}